- Home
- LIDR vs FBRX Comparison
LIDR vs FBRX Comparison
Compare LIDR & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- FBRX
- Stock Information
- Founded
- LIDR 2013
- FBRX N/A
- Country
- LIDR United States
- FBRX United States
- Employees
- LIDR N/A
- FBRX N/A
- Industry
- LIDR Auto Parts:O.E.M.
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- LIDR Consumer Discretionary
- FBRX Health Care
- Exchange
- LIDR Nasdaq
- FBRX Nasdaq
- Market Cap
- LIDR 9.8M
- FBRX 8.3M
- IPO Year
- LIDR N/A
- FBRX N/A
- Fundamental
- Price
- LIDR $1.10
- FBRX $18.75
- Analyst Decision
- LIDR Hold
- FBRX Strong Buy
- Analyst Count
- LIDR 1
- FBRX 3
- Target Price
- LIDR N/A
- FBRX $77.58
- AVG Volume (30 Days)
- LIDR 547.8K
- FBRX 1.7M
- Earning Date
- LIDR 11-12-2024
- FBRX 11-14-2024
- Dividend Yield
- LIDR N/A
- FBRX N/A
- EPS Growth
- LIDR N/A
- FBRX N/A
- EPS
- LIDR N/A
- FBRX N/A
- Revenue
- LIDR $225,000.00
- FBRX N/A
- Revenue This Year
- LIDR N/A
- FBRX N/A
- Revenue Next Year
- LIDR $2,650.00
- FBRX N/A
- P/E Ratio
- LIDR N/A
- FBRX N/A
- Revenue Growth
- LIDR N/A
- FBRX N/A
- 52 Week Low
- LIDR $0.78
- FBRX $4.11
- 52 Week High
- LIDR $5.15
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- LIDR 48.53
- FBRX 52.67
- Support Level
- LIDR $1.07
- FBRX $18.33
- Resistance Level
- LIDR $1.64
- FBRX $24.64
- Average True Range (ATR)
- LIDR 0.15
- FBRX 3.23
- MACD
- LIDR 0.01
- FBRX -0.99
- Stochastic Oscillator
- LIDR 18.18
- FBRX 8.56
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).